198 related articles for article (PubMed ID: 12369607)
21. Venlafaxine: a novel antidepressant that has a dual mechanism of action.
Andrews JM; Ninan PT; Nemeroff CB
Depression; 1996; 4(2):48-56. PubMed ID: 9160640
[TBL] [Abstract][Full Text] [Related]
22. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
Möller HJ; Volz HP
Drugs; 1996 Nov; 52(5):625-38. PubMed ID: 9118813
[TBL] [Abstract][Full Text] [Related]
23. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
24. Nefazodone and venlafaxine: two new agents for the treatment of depression.
Goldberg RJ
J Fam Pract; 1995 Dec; 41(6):591-4. PubMed ID: 7500069
[TBL] [Abstract][Full Text] [Related]
25. Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?
Wong DT; Bymaster FP
Prog Drug Res; 2002; 58():169-222. PubMed ID: 12079200
[TBL] [Abstract][Full Text] [Related]
26. Milnacipran. A review of its use in depression.
Spencer CM; Wilde MI
Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315
[TBL] [Abstract][Full Text] [Related]
27. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
[TBL] [Abstract][Full Text] [Related]
28. Status of treatment of depression.
Broquet KE
South Med J; 1999 Sep; 92(9):846-56. PubMed ID: 10498158
[TBL] [Abstract][Full Text] [Related]
29. [Review of antidepressants from the TCAs to the third generation drugs].
Almási J; Rihmer Z
Neuropsychopharmacol Hung; 2004 Dec; 6(4):185-94. PubMed ID: 15825674
[TBL] [Abstract][Full Text] [Related]
30. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
Mukai Y; Tampi RR
Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
[TBL] [Abstract][Full Text] [Related]
31. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
Puech A; Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
[TBL] [Abstract][Full Text] [Related]
32. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development.
Montgomery S
Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():5-11. PubMed ID: 24921676
[TBL] [Abstract][Full Text] [Related]
33. Rapid onset of action of venlafaxine.
Montgomery SA
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():21-7. PubMed ID: 7622814
[TBL] [Abstract][Full Text] [Related]
34. [New antidepressive drugs in comparison with classical tricyclics. Mechanism of action and clinical evaluation].
Broocks A; Junghanns K; Thiel A; Gleiter CH; Bandelow B
Fortschr Neurol Psychiatr; 2000 Jan; 68(1):17-24. PubMed ID: 10705571
[TBL] [Abstract][Full Text] [Related]
35. Differential pharmacology of newer antidepressants.
DeVane CL
J Clin Psychiatry; 1998; 59 Suppl 20():85-93. PubMed ID: 9881541
[TBL] [Abstract][Full Text] [Related]
36. Japanese experience with dual-action antidepressants.
Tajima O
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-42. PubMed ID: 12369609
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacological justification for the use of new antidepressant drugs].
Nowakowska E; Kus K; Bobkiewicz-Kozłowska T
Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
[TBL] [Abstract][Full Text] [Related]
38. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
39. Triple uptake inhibitors: therapeutic potential in depression and beyond.
Chen Z; Skolnick P
Expert Opin Investig Drugs; 2007 Sep; 16(9):1365-77. PubMed ID: 17714023
[TBL] [Abstract][Full Text] [Related]
40. Redefining antidepressant efficacy toward long-term recovery.
Thase ME
J Clin Psychiatry; 1999; 60 Suppl 6():15-9. PubMed ID: 10235120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
